The latest immunotherapy news and developments
Loss of the “housekeeping” gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer. Patients with…
Treating cancer with immune checkpoint blockade (ICB) prior to surgery (neoadjuvant immunotherapy) has been a…
Scientists from Tokyo Metropolitan University in Japan have realized a new polymer that can effectively…
Results from the randomised Phase 3 clinical trial (Atalante-1) on T-cell epitope cancer vaccine in HLA-A2…
DNA mismatch repair deficiency (MMRd) is a genetic condition often associated with colon cancer. It…
In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell…
Metabolites produced by gut bacteria during digestion can be used to trigger an immune response…
Scientists identify a new and surprising function of a membrane protein on the surface of cancer…
In recent years, scientists have used gene modification technologies to reprogram immune cells into therapeutics…
Musicians from across the world have released a new single as part of a campaign…